SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the six months ended June 30, 2023 and 2022:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Six Months Ended on June 30, 2023
Revenue	$	19,515,728		$	28,074		$	12,786		$	524,196		$	20,080,784
Cost of Sales		(12,168,470	)		(9,139	)		(109,657	)		(140,508	)		(12,427,774	)
Gross Margin		7,347,258			18,935			(96,871	)		383,688			7,653,010
Operating Expenses		(992,201	)		(202,430	)		(477,917	)		(2,960,696	)		(4,633,244	)
Operating Loss		6,355,057			(183,495	)		(574,788	)		(2,577,008	)		3,019,766
Other Income (Expense)		215,306			(1,091,514	)		835,888			(13,116,034	)		(13,156,354	)
Net Loss Before Income Tax	$	6,570,363		$	(1,275,009	)	$	261,100		$	(15,693,042	)	$	(10,136,588	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Six Months Ended on June 30, 2022
Revenue	$	1,924,916		$	7,701		$	749,693		$	196,267		$	2,878,577
Cost of Sales		(1,625,942	)		(2,792	)		(11,985	)		(24,508	)		(1,665,227	)
Gross Margin		298,974			4,909			737,708			171,759			1,213,350
Operating Expenses		(1,320,957	)		(159,976	)		(910,246	)		(2,129,974	)		(4,521,153	)
Operating (Loss) Income		(1,021,983	)		(155,067	)		(172,538	)		(1,958,215	)		(3,307,803	)
Other Expense		209			(764,968	)		(3,039,097	)		(10,579,541	)		(14,383,397	)
Net Loss Before Income Tax	$	(1,021,774	)	$	(920,035	)	$	(3,211,635	)	$	(12,537,756	)	$	(17,691,200	)
June 30, 2023
Cash and Restricted Cash	$	2,209,538		$	461,704		$	991,986		$	25,828,907		$	29,492,135
Total Assets		61,091,436			3,516,613			5,136,085			98,697,677			168,441,811
December 31, 2022
Cash and Restricted Cash	$	2,592,577		$	514,260		$	1,338,404		$	14,076,662		$	18,521,903
Total Assets		57,951,324			3,184,416			4,861,615			87,492,981			153,490,336